Read the press release here.
Clinical Publication Group
Investing In and Evolving Products to their Fullest Potential
July 6, 2021
C2Dx, Inc is a privately held medical device company based in Kalamazoo, Michigan with a unique business model. Founded in early 2019 by industry experts, C2Dx continues to build its business from the strong foundation of its initial acquisition of the STIC Intra-Compartmental Pressure Monitor from Stryker. Seeing success from giving this product dedicated attention
The Shaw Scalpel System as an Alternative to Electrocautery in Patients with Pacemakers
June 13, 2021
The Shaw Hemostatic Scalpel as an Alternative to Electrocautery in Patients with Pacemakers Authors: David Amar, M.D., David H. Fogel, M.D., Jatin P. Shah, M.D.
The Use of the Shaw Scalpel System in Operations Upon the Breast
June 13, 2021
The Use of the Hemostatic Scalpel in Operations Upon the Breast Author: Samuel Pilnik, M.D., F.A.C.S.; Felicien Steichen, M.D., F.A.C.S.
State-level economic costs of opioid use disorder and fatal opioid overdose
April 16, 2021
Published by Centers for Disease Control and Prevention The U.S. economic cost of opioid use disorder ($471 billion) and fatal opioid overdose ($550 billion) during 2017 totaled $1,021 billion. In the 39 jurisdictions studied, combined costs of opioid use disorder and fatal opioid overdose varied from $985 million in Wyoming to $72,583 million in Ohio.
The Shaw Scalpel – Thermal Control of Surgical Bleeding
April 13, 2021
The Shaw Scalpel – Thermal Control of Surgical Bleeding Author: W. James Gallo, Martin Moss, John V. Gaul
The Advantage of the Shaw Heated Scalpel in Operations for Breast Cancer
April 13, 2021
The Advantage of the Shaw Heated Scalpel in Operations for Breast Cancer Authors: Kiyotaka Tonaka, Yasuaki Gyohda, Miyuki Yokota, Yuichi Tsukada, Makoto Seki, Masonori Uchiyama
Wound Healing and the Shaw Scalpel
March 13, 2021
Wound Healing and the Shaw Scalpel Author: Donna J. Millay, MD; Ted A. Cook, MD; Robert E. Brummett, PhD: Edward L. Nelson; Patricia L. O’Neill, PhD
C2Dx acquires Stryker T/Pump product line
February 18, 2021
A medical device startup acquired a line of devices that provide localized temperature therapy for pain relief and patient comfort. Kalamazoo-based C2Dx — a medical device company founded in 2019 that invests in and refines the delivery of “valuable niche products” to propel their growth — said Tuesday that it acquired the T/Pump product line
Chronic Exertional Compartment Syndrome in a High School Soccer Player
February 18, 2021
This case of a young 15-year-old high school soccer play demonstrates why chronic exertional compartment syndrome should be considered by emergency medicine physicians, coaches, trainers, therapists, and others with patients with more serious pain associated with exercise that does not cease with rest. Abstract Chronic exertional compartment syndrome (CECS) is a condition that commonly affects
Kalamazoo’s C2Dx Acquires T/Pump Product Line from Stryker
February 17, 2021
Medical device company C2Dx Inc. has acquired the T/Pump product line from Stryker Corp. Both firms are based in Kalamazoo, which has become a medical technology powerhouse highlighted by the COVID-19 vaccine being produced by Pfizer. Kalamazoo also is home to multiple medical technology parks, Western Michigan University, and is a large producer of medical